OPUS IP
      
 
  • Home
  • ABOUT OPUS IP
    • INTELLECT
    • PRACTICALITY
  • PROTECTION
    • PATENTS
    • FILING A PATENT APPLICATION
    • REGISTERED DESIGNS
    • REGISTERED TRADEMARKS
    • COPYRIGHT
  • IP OFFICES
    • UKIPO
      • NEWS/UPDATES
      • RECENT HEARINGS
        • PATENTS
        • TRADEMARKS
        • DESIGNS
      • UK PATENTS COURT DECISIONS
      • UK IPEC DECISIONS
    • EPO
      • NEWS/UPDATES
        • EPO GENERAL
        • EPO FEES
        • EPO OFFICIAL JOURNAL
        • EPO ONLINE SERVICES
        • EPO SEARCHING
      • APPEAL DECISIONS
        • G/XX DECISIONS 2010-2019
        • G/XX DECISIONS 2000-2009
        • G/XX DECISIONS 1990-2000
        • G/XX DECISIONS PRE-1990
        • J/XX APPEALS 2010-2019
        • J/XX APPEALS 2000-2009
        • J/XX APPEALS 1990-2000
        • J/XX APPEALS PRE-1990
        • T/XXXX APPEALS 2010-2019
        • T/XXXX APPEALS 2000-2009
        • T/XXXX APPEALS 1990-1999
        • T/XXXX APPEALS pre-1990
    • WIPO – PCT/MADRID/HAGUE
      • NEWS/UPDATES
        • PCT NEWSLETTER
        • PATENTS NEWS
        • TREATY MODIFICATIONS
        • MADRID SYSTEM (TM)
        • HAGUE SYSTEM (DESIGNS)
        • PATENTSCOPE/SEARCHING
      • PCT COUNTRIES/REGIONS
      • PARIS NOT PCT COUNTRIES
    • USPTO
      • NEWS/UPDATES
        • GENERAL
        • PATENTS
        • TRADEMARKS
        • COPYRIGHT
      • USPTO RECENT CASES
    • EUIPO
      • NEWS/UPDATES
        • EUIPO GENERAL NEWS
        • EUIPO LEGAL NEWS
        • EUIPO DESIGNS NEWS
        • EUIPO WEBSITE NEWS
      • SEARCH CASES (EXTERNAL)
  • IP NEWS/LINKS
    • LATEST NEWS SUMMARY
    • LINKS TO IP RESOURCES
    • GLOBAL IP NEWS
      • The IPKat BLOG
      • PATENT NEWS
      • DESIGN NEWS
      • TRADEMARK NEWS
      • COPYRIGHT NEWS
  • SITE
    • RSS FEEDS & SITE HIERARCHY
    • COMPETE PAGE LIST
    • COMPLETE POST LIST
  • LOG-IN
 

PATENT NEWS

  • In: PATENT NEWS

    Can soaring prescription drug costs be controlled? Some state legislators think so

    Price spikes among older and generic drugs have led others to believe drug companies take advantage of patent protections provided under federal law to impose monopoly pricing. Some long-existing drugs like Epipen, the life-saving medicine for people with severe allergies, have seen enormous …

     
  • In: PATENT NEWS

    If I cannot take patent bar, what’s my prospect of pursuing an IP career in the US

    Heyy TLS, long time no see! I’ve been out of this law school world for a while, but last month I received a surprise T13 offer, which again put me in the to-go-or-not-to-go delimma. I have a solid background in computer science and wanted to be an IP lawyer. As... Continue reading

     
  • In: PATENT NEWS

    Work Product Samples

    Malone IP Law High Quality Low Cost Patents · Home · Free Consultation · Work Product Samples. More. Home · Free Consultation · Work Product Samples. ✕. Home · Free Consultation · Work Product Samples …

     
  • In: PATENT NEWS

    In-house Patent Formalities Officer

    A fantastic opportunity for an experienced IP professional to join a well-established in-house legal department. You will assist the patent attorneys with the protection of the firm s global patent portfolio. Candidates should have experience working with UK, EP and PCT applications and hold a sound …

     
  • In: PATENT NEWS

    Fitbit Wants Rival Sanctioned After Beating IP Suit

    Law360 (February 23, 2018, 8:54 PM EST) — A Fitbit Inc. rival should be sanctioned for not conducting the simplest of investigations before claiming Fitbit infringed a patent covering its motion detection technology, the company told a California federal court in a renewed push to have the …

     
  • In: PATENT NEWS

    Patent Office Puts Allergan’s Mohawk Deal Out Of Its Misery

    Patent Office Puts Allergan’s Mohawk Deal Out Of Its Misery  Seeking Alpha Full coverage

     
  • In: PATENT NEWS

    Patent Office Puts Allergan’s Mohawk Deal Out Of Its Misery

    Source: GW Law – The George Washington University. In a much-anticipated ruling the Patent Trial And Appeal Board (“PTAB”) of the U.S. Patent And Trademark Office ruled the St. Regis Mohawk Tribe could not claim sovereign immunity to void an inter partes review (“IPR”) for dry-eye drug Restasis:.

     
  • In: PATENT NEWS

    Microbiome patent update

    February 23, 2018. Patent Law Alert. Author(s): Mark James FitzGerald, Ph.D., David S. Resnick. In this issue: Analyses of interesting claims of some recently issued U.S. patents; Notes on microbiome-related patents challenged under the Opposition procedure in the European Patent Office; Some …

     
  • In: PATENT NEWS

    Decided Guidance: Case Examinations—Taylor and Quarles v. Brown

    It came up with this answer “It is a fact of universal notoriety in Virginia not only that the old military surveys but that the old patents of that country generally contain a greater quantity of land than the patents call for. The ancient law of Virginia notices this fact... Continue reading

     
  • In: PATENT NEWS

    Fish & Richardson client prevails in reversal of $2.5 billion jury verdict in Del.

    Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in … Fish has been representing Gilead for over five years in its worldwide, complex patent battle with Merck and Idenix (now owned... Continue reading

     
← Previous 1 … 8,241 8,242 8,243 8,244 8,245 … 8,432 Next →
 
 
 

OPUS IP LIMITED

Orchard House
41 Altrincham Road
Wilmslow
SK9 5NG
United Kingdom

t.: +44 (0) 800 047 8107
e.: [email protected]

opusipuk

CLICK FOR LOCATION MAP

 
 

OPUS IP On X (Formerly Twitter)…

opusipuk opusipuk @opusipuk ·
19 Mar

https://www.opusip.co.uk/2025/03/19/cbmixwfbvv95cuxongxkz3rdn21jzwdpnnbnuvhsrnjrvhlju0ktsgfuzlpraldsa1otzuhsdul4a1nfn2fdnkdpcfpyvtzstmxhtnjrdthtn0nketbvu0zhndvqwuo5rujytev4wwfmsejyelhpu09oshbknf93tzj6dk13owrbskhhx0z5sty5akg2snnfnfl4v2th/ Thaler denied copyright for AI-authored work, DC Circuit affirms - MLex
Thaler denied copyright for AI-authored...

Twitter 1902340381871612393
opusipuk opusipuk @opusipuk ·
19 Mar

https://www.opusip.co.uk/2025/03/19/cbmi4wjbvv95cuxnmk43vetqvgnrzfliefhkbzrhmvc4udcwmhgyd1hmalvreuzitddwu1vsdmz5zgjsxy1qmnrobkjdmurmuhm0akfxt3nzwujjsgpmwnhuy2mxrnrsnhdostjbtghfr2tzunawnxjuwfj3ni1mrehpt2zhm3i3b2cwrwhnsf9uamtid1fqq2hfvmfx/ Hollywood vs. AI: Over 400 stars including Ben Stiller, Paul McCartney, Aubrey Plaza demand Trump admin bl - The ...

Twitter 1902340183909134393
opusipuk opusipuk @opusipuk ·
19 Mar

https://www.opusip.co.uk/2025/03/19/cbmiyafbvv95cuxna3vdcl9xa3dsdji0x055ogkwmu84t3lbawpbm3bprwkyri1xrg14zvj5ylhlbnd1bvzpsgncx0dhaefpr3donhbalu5isnfjm2r0di0yz2rrwdr0zgdryko5rlrgb2frdu0yzxpnykzxanzesvjlm3j0s0m0uwy3ak1lbmhltu92qk16etbeudzh/ Viral DRM lacks standing in YouTube copyright suit, US judge says - MLex
Viral DRM lacks standing in YouTube co...

Twitter 1902339990857588802
opusipuk opusipuk @opusipuk ·
19 Mar

https://www.opusip.co.uk/2025/03/19/cbmiywfbvv95cuxoq0twdjmtwgljq250quphrfdrbgpxnev5qulzylh0y2iymglsrmfoww41eun2ovnhdjndte4twkntte9freq0rnytshdfothcu19pbjbxqnrxbwlvehvste9ate1us2i2bmxunmloevf1mwjdvxgzawrkm3h5mutmoe5pvv9msfhxdwc2q08tnw9i/ ICO publishes response to the UK Government’s copyright and AI consultation - Ropes & Gray LLP
ICO publishes re...

Twitter 1902339937892233285
 
 

RSS RECENT PATENT NEWS…

  • Grundfos Holding pump patent infringed by Chinese rival, UPC finds - MLex
  • Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder - BioSpace
  • Navigating The GLP-1 Litigation Landscape - Life Science Leader
  • ToolGen and Vertex focus battle over CRISPR/Cas therapy Casgevy in Europe - JUVE Patent
 
 

RSS UK BUSINESS NEWS…

  • UK interest rates cut to lowest for two years
  • UK interest rates cut to lowest for two years
  • UK inflation rate: How quickly are prices rising?
  • Sports kits that 'don't last' push prices 'up and up and up'
 
 
 

Designed by Industrial Action

Copyright © 2025 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION